antibody

Documents about antibody

• Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma#881022ClinicalTrials.gov
• Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients#882473ClinicalTrials.gov
• Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers#884645ClinicalTrials.gov
• Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma#890888ClinicalTrials.gov
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)#891477ClinicalTrials.gov
• CHOZN® CHO K1 cell line development platform optimization for production of therapeutic recombinant proteins#8224HAL (France)
• Analytical and Clinical Validation of a Remote Laboratory Test for Prothrombin Time and INR Determination in Patients with Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus.#199189NCBI PubMed Central
• Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model#202532HAL (France)
• Study of CDK4/6 Inhibitor Combined With PD-L1 Monoclonal Antibody in the Treatment of PD-1/PD-L1 Resistance and Abnormal Cell Cycle Digestive System Tumors#346940ClinicalTrials.gov
• PR3-ANCA associated vasculitis with rapidly progressive glomerulonephritis (RPGN): an uncommon cause of rapidly developing renal failure#361141The ESRF Research Journal for Undergraduate Medical Students
• The Influence of Beryllium on Cell Survival Rates in the In-vitro Culture System, on Intracellular DNA Synthesis and on SRBC-IgM Antibody Production Responses#383797CiNii
• Elevated Plasma Level of Circulating Immune Complexes in Nigerian Adults infected with Severe Acute Respiratory Syndrome Corona Virus-2#390201University of Ibadan Institutional Repository
• A DEFINITIVE TCRBETA1/ TCRBETA2 ANTIBODY PAIR FOR DETERMINING T-CELL MONOTYPIA AS A SURROGATE FOR CLONALITY IN LYMPHOMA DIAGNOSIS IN FORMALIN FIXED PARAFFIN EMBEDDED MATERIAL#422506Europe PMC
• Supplementary file 1_Age-related differences in BMD response during three years of denosumab treatment.docx#448616Figshare
• Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity#484952Europe PMC
• Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma#800299ClinicalTrials.gov
• Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors#802675ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma#827794ClinicalTrials.gov
• Paradoxical Tuberculosis Reactions in Patients Without HIV Infection#832501ClinicalTrials.gov
• A Phase II Study of Anti-PD-1 Antibody, Sintilimab, as Second-line Therapy for Biomarker-selected Advanced or Metastatic NSCLC#843602ClinicalTrials.gov
• A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.#847384ClinicalTrials.gov
• A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab#850558ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer#850804ClinicalTrials.gov
• A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer#855419ClinicalTrials.gov
• A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19#871000ClinicalTrials.gov
• Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine#893666ClinicalTrials.gov
• Should WHO-prequalified antigen-antibody fourth-generation rapid diagnostic tests be used to detect acute HIV infection? A systematic review and meta-analysis of diagnostic performance#28602bioRxiv / medRxiv
• Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer#146435ClinicalTrials.gov
• ABO-incompatible kidney transplantation: impact of apheresis on graft and patient survival in recipients with low isoagglutinin titer#284396HAL (France)
• First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients.#308802NCBI PubMed Central
• Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™#321538ClinicalTrials.gov
• Investigation of the Effect of Arginine and Glutathione on Recovery of a Single Domain Antibody Produced in Bacteria in Inclusion Bodies#376923İzmir Yüksek Teknoloji Enstitüsü
• Biochemical and biological characterization of cathepsin selective ADCs in HER2 positive breast cancer#396759RepOD Dataverse OAI Archive
• Different levels of humoral and cellular immunity to varicella-zoster virus in seropositive healthcare workers#450666S-Space: Seoul National University
• The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine#459976ClinicalTrials.gov
• A TCR-mimic bispecific antibody reduces HIV-1 provirus and delays viral rebound in HLA-matched humanized mice#484965Europe PMC
• Anti-malaria antibody engineering broadens recognition motifs and reveals new homotypic interactions that enhance protective breadth#485003Europe PMC
• Monitoring antibody binding events in homogeneous solution by single-molecule fluorescence spectroscopy#492908Bielefeld Pub
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial#628521ClinicalTrials.gov
• Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia#805796ClinicalTrials.gov
• A Phase Ⅰa Clinical Study Exploring Efficacy of SIBP-03 When Treating the Patients With Advanced Malignant Solid Tumors.#812656ClinicalTrials.gov
• 3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)#812863ClinicalTrials.gov
• Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study#846459ClinicalTrials.gov
• Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases#858028ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia#860532ClinicalTrials.gov
• HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02#861545ClinicalTrials.gov
• Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia#861774ClinicalTrials.gov
• Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)#867317ClinicalTrials.gov
• Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant#871396ClinicalTrials.gov
• An Open-label Study of SG1827 Combined With Anti-PD-1/PD-L1 Antibody and Bevacizumab in Patients With Advanced Solid Tumors#873674ClinicalTrials.gov